I'm LongbridgeAI, I can summarize articles.Edwards Lifesciences Holding increased its stake in Carvolix to 11.65% of capital and 9.07% of voting rights on June 26, 2026, through a capital increase subscription. The holding now owns 7,248,035 shares. Edwards stated it may participate in future capital increases but does not seek control or board representation.
- Edwards Lifesciences Holding crossed above the 10% capital threshold on June 26, 2026 via a capital increase subscription. * It held 7,248,035 shares, equal to 11.65% of capital, representing 9.07% of voting rights. * Edwards said it may join future capital increases, without seeking control or board representation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carvolix SA published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here